US NIH starts Covid booster study in people with autoimmune disease
Study participants will be followed for a total of 13 months. Preliminary results are expected in November 2021, the statement said
Study participants will be followed for a total of 13 months. Preliminary results are expected in November 2021, the statement said
'At a time when treatments are being tested with urgency amid the COVID-19 pandemic, our study results offer some hope towards finding solutions to better treat patients infected by this disease,' said study researcher Manish Sagar from the Boston University in the US.
